Loading...
Nephros, Inc.
NEPH•NASDAQ
Healthcare
Medical - Instruments & Supplies
$3.57
$0.13(3.78%)
Nephros, Inc. (NEPH) Financial Performance & Income Statement Overview
Review Nephros, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-0.53%
↓ 0.53%
Operating Income Growth
100.38%
↑ 100.38%
Net Income Growth
104.70%
↑ 104.70%
Operating Cash Flow Growth
-159.49%
↓ 159.49%
Operating Margin
4.98%
↑ 4.98%
Gross Margin
62.45%
↑ 62.45%
Net Profit Margin
5.16%
↑ 5.16%
ROE
9.43%
↑ 9.43%
ROIC
7.52%
↑ 7.52%
Nephros, Inc. (NEPH) Income Statement & Financial Overview
Review Nephros, Inc.'s (NEPH) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $3.87M | $3.52M | $3.25M | $3.52M |
Cost of Revenue | $1.40M | $1.37M | $1.37M | $1.37M |
Gross Profit | $2.48M | $2.15M | $1.88M | $2.15M |
Gross Profit Ratio | $0.64 | $0.61 | $0.58 | $0.61 |
R&D Expenses | $252000.00 | $188000.00 | $254000.00 | $212000.00 |
SG&A Expenses | $1.87M | $1.72M | $1.94M | $2.14M |
Operating Expenses | $2.16M | $1.94M | $2.19M | $2.35M |
Total Costs & Expenses | $3.52M | $3.31M | $3.57M | $3.72M |
Interest Income | $28000.00 | $20000.00 | $21000.00 | $25000.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $1000.00 |
Depreciation & Amortization | $36000.00 | $34000.00 | $34000.00 | $33000.00 |
EBITDA | $400000.00 | $240000.00 | -$255000.00 | -$135000.00 |
EBITDA Ratio | $0.10 | $0.07 | -$0.08 | -$0.04 |
Operating Income | $317000.00 | $206000.00 | -$317000.00 | -$200000.00 |
Operating Income Ratio | $0.08 | $0.06 | -$0.10 | -$0.06 |
Other Income/Expenses (Net) | $47000.00 | -$23000.00 | $28000.00 | $31000.00 |
Income Before Tax | $364000.00 | $183000.00 | -$289000.00 | -$169000.00 |
Income Before Tax Ratio | $0.09 | $0.05 | -$0.09 | -$0.05 |
Income Tax Expense | $15000.00 | $0.00 | $0.00 | -$10276.00 |
Net Income | $349000.00 | $183000.00 | -$289000.00 | -$169000.00 |
Net Income Ratio | $0.09 | $0.05 | -$0.09 | -$0.05 |
EPS | $0.03 | $0.02 | -$0.03 | -$0.02 |
Diluted EPS | $0.03 | $0.02 | -$0.03 | -$0.02 |
Weighted Avg Shares Outstanding | $10.54M | $10.54M | $10.51M | $10.50M |
Weighted Avg Shares Outstanding (Diluted) | $10.56M | $10.58M | $10.51M | $10.50M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan